Your session is about to expire
← Back to Search
Web-based Family Therapy Training for Mental Health Practice Improvement
N/A
Recruiting
Led By David Santisteban, PhD
Research Sponsored by Training and Implementation Associates
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial compares a new online training tool for mental health therapists with traditional in-person training. It aims to see if the online tool is just as effective in improving therapist skills, helping families, and preparing agency leaders. The platform uses interactive lessons and feedback to adapt the training based on progress.
Who is the study for?
This trial is for mental health therapists and agency leaders. Therapists must be treating youth, have no recent family therapy training, and agree to train and apply a new treatment with a family. They need at least 2 years of experience or relevant qualifications. A child aged 11-18 and their caregiver will participate per therapist. Agency leaders should manage resources to support the study.
What is being tested?
The trial tests if web-based Family Therapy Training (FTTIP) is as effective as traditional in-person training for therapists learning family therapy skills. It measures improvements in therapy competencies, agency readiness, and client outcomes after training with FTTIP versus usual methods.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from participating in the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from pre therapy to post therapy treatment in adolescent behavior problems as measured by The Achenbach System of Empirically Based Assessments Brief Problem Monitoring (BPM) for 6-18 year old Scales
Change from pre therapy to post therapy treatment in family cohesion and family conflict as measured by the Family Environment Scale
Change in organizational readiness as measured by Training and Implementation Associates (TIA) Organizational Readiness Measure, Director Form
+4 moreSecondary study objectives
Activities related to agency readiness as measured by The Organizational Readiness Consultation Activity Log
Satisfaction with the CIFFTA evidenced based treatment as measured by a 10 question survey about satisfaction.
Therapeutic alliance as measured by the Working Alliance Inventory (WAI) short form
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
5Treatment groups
Experimental Treatment
Active Control
Group I: Family Therapy Training and Implementation Platform (FTTIP)Experimental Treatment1 Intervention
Participants will be trained for 20 hours on an online platform practicing family therapy competencies with animated families and provided recorded video responses to receive feedback from trainers.
Group II: Culturally Informed and Flexible Family-Based Treatment for Adolescents (CIFFTA).Experimental Treatment1 Intervention
All of the 150 families will receive Family Therapy, Individual Therapy, and Psycho-educational Modules, delivered over 16 weeks in a two session (60 minutes each) per week format.
Group III: Agency Readiness Consultation- Family Therapy Training and Implementation Platform (FTTIP)Experimental Treatment1 Intervention
Agency leaders assigned to this condition will complete an online assessment of agency readiness, participate in a webinar and live discussion, complete an online meeting with leaders and clinical supervisors
Group IV: Agency Engagement and Orientation as UsualActive Control1 Intervention
Agency leaders assigned to this condition will receive a traditional engagement of leadership at their agency including a description of study procedures and engagement with study team.
Group V: Traditional in person Training as UsualActive Control1 Intervention
Participants will attend 20 hours of a traditional in person training learning about the family therapy evidenced based treatment.
Find a Location
Who is running the clinical trial?
Training and Implementation AssociatesLead Sponsor
1 Previous Clinical Trials
36 Total Patients Enrolled
1 Trials studying Traditional Face to Face Training
36 Patients Enrolled for Traditional Face to Face Training
Daniel Santisteban, PhDStudy DirectorTraining and Implementation Associates
David Santisteban, PhDPrincipal InvestigatorTraining and Implementation Associates
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My gender, race, or ethnicity does not affect my eligibility.I am currently treating youth and can provide family intervention during the project.I am willing to work with a family (1 child aged 11-18 and their caregiver).I can allocate resources and am willing to engage in readiness and implementation advice.
Research Study Groups:
This trial has the following groups:- Group 1: Culturally Informed and Flexible Family-Based Treatment for Adolescents (CIFFTA).
- Group 2: Family Therapy Training and Implementation Platform (FTTIP)
- Group 3: Agency Readiness Consultation- Family Therapy Training and Implementation Platform (FTTIP)
- Group 4: Agency Engagement and Orientation as Usual
- Group 5: Traditional in person Training as Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.